The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AmMax Bio; Daiichi Sankyo/Lilly; Johnson & Johnson/Janssen; Onkos Surgical; Stryker
Travel, Accommodations, Expenses - Onkos Surgical; Stryker
CINSARC score use in pediatric non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) in the Children’s Oncology Group (COG) studies ARST0332 and ARST1321.
 
Rachel M Hurley
No Relationships to Disclose
 
Lei Guo
No Relationships to Disclose
 
Donald A. Barkauskas
Employment - Genentech (I)
Patents, Royalties, Other Intellectual Property - U.S. patent based on Ph.D. research in glioblastoma (I)
 
Lei Yu
Employment - Gilead Sciences
 
Yen-Lin Chen
Employment - Massachusetts General Physician Organization
 
Lauren Gutstein
Employment - Children's Hospital of Philadelphia; Fox Chase Cancer Center
 
Douglas S. Hawkins
Research Funding - Bayer Health (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Pfizer (Inst)
 
Thomas Scharschmidt
No Relationships to Disclose
 
Stephen X Skapek
No Relationships to Disclose
 
Sheri L. Spunt
Research Funding - Bayer HealthCare Pharmacuticals (Inst); Medpace (Inst)
 
Dian Wang
No Relationships to Disclose
 
Aaron R. Weiss
Consulting or Advisory Role - BioAtla
Travel, Accommodations, Expenses - SpringWorks Therapeutics
 
Lin Xu
No Relationships to Disclose
 
Theodore Willis Laetsch
Stock and Other Ownership Interests - Advanced Microbubbles
Honoraria - Cook Children's Hospital
Consulting or Advisory Role - AI Therapeutics; Aptitude Health; Bayer; GentiBio; ITM Oncologics; Jazz Pharmaceuticals; Jumo Health; Massive Bio; Medscape; Menarini; Novartis; Pyramid Biosciences; Targeted Oncology; Treeline Biosciences
Research Funding - Advanced Accelerator Applications/Novartis; Bayer (Inst); BioAtla; Bristol-Myers Squibb; Lilly; Pfizer (Inst); Roche; Roche/Genentech; Taiho Oncology; Turning Point Therapeutics (Inst)